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Abstract
Background: Headache disorders cause substantial productivity losses through absenteeism and impaired
effectiveness at work (presenteeism). We had previously found these losses to be high in a mostly male, heavy-
manufacturing workforce at Ford Otomotiv Sanayi AŞ (FO), in north-western Turkey. Here we aimed to confirm this
finding in a year-long study to eliminate any effect of seasonal variation. The question then was how much of this
lost productivity could be recovered by the effective provision of headache care.
Methods: We used the HALT-30 Index to estimate productivity losses, surveying FO’s entire workforce (N = 7,200)
during annual health-checks provided by the company’s on-site health clinic. Then we established, and widely
advertised, a headache clinic within the same health clinic, providing specialist care free for 15 months. Outcome
measures were HALT-30, company sickness records and the HURT questionnaire.
Results: Usable data were collected from 5,916 employees (82.2 %; 5,485 males [92.7 %], 431 females [7.3 %]; mean
age 32.5 ± 5.4 years). One-month headache prevalence was 45.4 % (n = 2,688). Productivity losses were reported by
968 employees (16.4 %) and, per affected employee, increased from 0.23 to 7.56 days/month as headache
frequency increased (P <0005). Employees reporting headache on ≥15 days/month (n = 64; 1.1 %) accounted for
21.1 % of productivity losses, those with headache on 10–14 days (n = 104; 1.8 %) another 18.5 %. With increasing
headache frequency, absenteeism/presenteeism ratio (overall 1:16) declined from about 1:4 to about 1:25 in those
with headache on ≥10 days/month. Headache frequency and lost productivity were higher in females than males
(P <0.0005). Both absenteeism and presenteeism rates declined after age 34 years (P <0.0005).
Only 344 employees with headache (12.8 %) requested appointments, and only 211 (7.8 %) actually consulted.
Attendance was related to headache frequency (P <0.0005). Too few returned for follow-up to allow useful
outcome assessment.
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Conclusion: The high productivity losses in this young mostly male workforce correlated with but were not wholly
explained by headache frequency. A small minority of employees with high-frequency headache contributed highly
disproportionately to the productivity losses. These should be the target of interventions aimed at productivity
recovery. It is not clear what form such interventions should take: making headache care optimally available is not
of itself sufficient.
Keywords: Headache disorders, Burden, Cost, Lost productivity, Work impact, Health care, Global campaign against
headache
Background
Headache disorders are now clearly recognised among
the major causes of disability within populations [1]. Im-
paired productivity and reduced output are measurable
consequences at national level [2–6], and the financial
costs are high [7, 8].
In our earlier report of productivity losses attributed to
headache disorders at Ford Otomotiv Sanayi AŞ (FO), a
vehicle-manufacturing company in north-western Turkey,
we described losses through absenteeism and, much more
substantial, those through impaired effectiveness at work
(presenteeism) [9]. We estimated that 2.4 % of workforce
capacity was surrendered to headache, 94 % of this due to
presenteeism. Such high productivity losses in a largely
male workforce might be surprising, but possible factors
were the nature of the work—manual labour for two
thirds, often heavy—and the recurring schedule distur-
bances of shift-work. We noted that a small minority
(5.7 %) of those with headache, who were only 2.5 % of
the workforce, accounted for >45 % of presenteeism-
related lost productivity.
Here we report a continuation of the original observa-
tional study, and a follow-up interventional study in the
same factory and workforce. We recorded productivity
losses within the entire workforce over a period of one
year, which allowed for any seasonal variation. Then, in
the interventional study, we established a headache clinic
within the factory’s on-site health clinic providing special-
ist ambulatory care free to employees. The purpose was to
remove barriers to care in order to investigate the extent
to which lost productivity attributable to headache could
be recovered by the effective provision of care.
The study was conducted as a project within the Global
Campaign against Headache [10–12].
Methods
Ethics
Since this was a project in preparation for and providing a
clinical service, it fell outside the scope of research ethics
review. While it involved access to company absenteeism
records, these were held legitimately by the employer.
Data-protection legislation was complied with. No per-
sonal information derived for the project passed beyond
the confines of the health clinic without first being made
anonymous.
Setting and population
At its manufacturing site in Gölcük, FO has a workforce
of 7,200 employees: about two thirds are manual
workers (90 % male) who rotate weekly through early,
late and night shifts, each of 8 h; the remainder are cler-
ical or managerial staff working a standard 5-day week,
8 am to 6 pm.
FO maintains sickness-absence records for its em-
ployees, which do not, however, include reasons for ab-
sence. The company provides an on-site health clinic,
staffed inter alia by primary health-care physicians and
nurses and providing care for day-to-day ailments. As a
service to its employees, the clinic also carries out and
records annual health-checks. These are offered, on a ro-
tating basis, to about 10 % of the workforce each month.
Lost productivity assessment
We used the Headache-Attributed Lost Time (HALT)
Index [13] translated into Turkish as the assessment in-
strument, as in our earlier study [9]. HALT enquires into
lost productivity during a preceding period: its first two
questions ask about absenteeism due to headache and
reduced productivity whilst at work with headache (pres-
enteeism). To estimate total productive time lost per
employee, reported in days/month, we added days
wholly lost through absenteeism and days of presentee-
ism with <50 % productivity; by way of counterbalance,
we ignored headache-affected days in which productivity
was nevertheless >50 %. We adopted the HALT-30 ver-
sion, which effectively sampled each individual’s head-
ache pattern over the preceding 30 days. We assumed,
in the total population, annual lost time was correctly
estimated from the sum of individual HALT-30 scores x
12. For purposes of comparison, we also calculated work
loss per week due either to absenteeism or to presentee-
ism. We took one work day as 8 h, and 1 month as
4 weeks, so that:
lost days=month  8½ =4 ¼ lost hours=week
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Over a 1-year period, HALT-30 was administered to
every employee attending his or her annual health-
check, along with the clinic’s own materials related to
the health-check. These forms were completed prior to
the health-check and handed to the supervising physician.
Data entry and management
Questionnaires were collected day by day and the data
transferred to Excel by one health technician. Subse-
quently, all Excel sheets were converted to SPSS (Statistical
Package for Social Sciences for Windows version 15.0).
Statistics
We used SPSS for descriptive statistical analyses, calcu-
lating (as appropriate) means, standard deviations and
medians. We used Student’s t-test, Pearson Χ2 and
Mann Whitney tests for significance of differences, and
Spearman or Pearson correlation coefficients for associa-
tions. We regarded P <0.05 as significant.
Intervention
With full support from senior management, we estab-
lished the headache clinic within the factory’s on-site
health clinic, with one of us (HMS), a headache special-
ist, providing ambulatory services on 2 days per week.
The service was advertised through posters at 28 sites in
the factory, through the factory’s intranet, by an inter-
view with HMS published in the factory’s monthly maga-
zine and by an educational talk about headache
disorders and the headache clinic given by HMS in the
factory conference hall and open to all employees. Ap-
pointments could be made by any employee, without
formality, through the secretary of the health clinic.
There was no selection or prioritisation according to
HALT-30 findings from the lost-productivity assessment:
a request for an appointment from any employee was
sufficient.
The headache service provided information, education
and life-style advice as part of good management, and
applied European principles of management [14] in allo-
cating time to new and follow-up appointments, in use
of ICHD diagnostic criteria [15], in selection of first-,
second- and third-line drugs and doses, in use of pro-
phylactics and in follow-up policy. Full records were
kept. Although the service itself was free to employees,
generally there were mandatory contributions of 20 % to
the costs of prescribed medications under the Turkish
health-care system.
The intervention continued for 15 months.
Outcome assessment
The principal measure of outcome was estimated days of
lost work-productivity per employee per year. We planned
three semi-independent approaches in order to assess the
effect of intervention.
HALT-30 in treated employees
HALT-30 was completed by patients when first attend-
ing for headache treatment, and again on discharge. The
change would be the primary outcome measure.
HALT-30 in the entire workforce
We continued to administer HALT-30 in the annual
health checks of all employees throughout the interven-
tion study. This method would provide data with a re-
sponse rate of close to 100 %, and include the effect of
headache in people who did not seek health care for it
(who might be the majority of those affected).
Company sickness records
There were complete records of sickness absences for the
entire workforce, although no reasons were captured. We
would calculate the total absences (days/week) for the
workforce throughout the period of the study. In a sec-
ondary analysis, we would look only at absences of ≤5 days’
duration (those of longer duration were less likely to be
headache-related). We did not intend to examine individ-
ual sickness records, since this might be objectionable
to participating employees and might influence their
behaviour.
Clinical outcome
We assessed clinical outcomes in each treated employee
during follow-up and on final discharge using the HURT
questionnaire [16].
Results
Observational study
Of the 7,200 total workforce, HALT-30 data were col-
lected from 5,940 (participation rate 82.5 %). Usable data
were available from 5,916: those with scores higher than
60 (the maximum possible) were discarded, as were
those who reported productivity loss (presumably from
other causes) but not headache. This sample (82.2 % of
the workforce) consisted of 5,485 males (92.7 %) and
431 females (7.3 %) with a mean age of 32.5 ± 5.4 (range
20–57) years; only 550 (9.3 %) were aged ≥40 years.
The 1-month headache prevalence was 45.4 % (n =
2,688). Productivity loss was reported by 968 employees,
who were 16.4 % of the sample and 36.0 % of those with
headache, and totalled 6,452 hours/week (380 hours/
week due to absenteeism and 6,072 hours/week due to
presenteeism). Mean lost productive time per employee
reporting any productivity loss (absenteeism and/or pres-
enteeism) was 6.7 hours/week. We divided the headache-
affected group into five sub-groups according to headache
frequency (Table 1). Over half (1,385; 23.4 % of the entire
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sample) reported 2–4 attacks, while 90 (1.5 %) reported
headache on ≥15 of the preceding 30 days. We observed a
steep increase in productivity loss per employee, from
0.23 to 7.56 days/month, as headache frequency increased
(Table 1) (Spearman correlation for absenteeism: 0.543
[P <0.0005]; for presenteeism: 0.149 [P <0.0005]). As a
consequence, the small sub-group reporting headache
on ≥15 days in the preceding month (n = 64), who
were 1.1 % of the entire sample, accounted for 21.1 %
of all productivity losses, and the only moderately lar-
ger sub-group (n = 104; 1.8 % of the sample) reporting
headache on 10–14 days were responsible for another
18.5 % (Table 1).
We also observed a consistent decline in absenteeism/
presenteeism ratio with increasing headache frequency,
from about 1:4 in those reporting one headache in the
preceding month to about 1:25 in those with headache
on ≥10 days/month (Table 1).
We investigated the effects of gender, age and nature
of work on absenteeism and presenteeism. Mean head-
ache attack incidence per month was higher in females
(2.9 ± 4.3) than in males (1.6 ± 3.0; P <0.0005 [Student’s
t-test]). Mean rates of absenteeism per employee were
0.03 ± 0.32 (median 0) days/month in females and 0.03 ±
0.39 (median 0) in males (P = 0.404 [Mann-Whitney]) and
of presenteeism were 1.16 ± 2.51 (median 0) for females
and 0.46 ± 1.67 (median 0) for males (P <0.0005 [Mann-
Whitney]).
Both absenteeism and presenteeism rates were age-
related (Table 2). After age 34 years, mean absenteeism
per employee fell from 0.04 ± 0.45 to 0.01 ± 0.15 days/
month (P <0.0005 [Student’s t-test]) and mean pres-
enteeism from 0.58 ± 1.91 to 0.36 ± 1.37 days/month
(P <0.0005 [Student’s t-test]).
The majority (82.6 %) of employees were blue-collar
(paint-house workers, press-metal workers, welders, as-
semblers, etc.); 17.4 % were white-collar (office workers,
including managerial staff ). Headache frequency in each
was similar, but more blue-collar employees (3.7 %) than
white (1.7 %) had headache on ≥15 days/month (Pearson
Χ2 = 10.135; P = 0.038). Mean absenteeism rate was higher
in blue-collar workers (0.04 ± 0.41 days/month) than white
(0.02 ± 0.21; P = 0.033 [Student’s t-test]), while mean pres-
enteeism rates were similar (0.52 ± 1.80 and 0.48 ±
1.53 days/month; P = 0.457).
Interventional study
We ran the clinic for 15 months, during which, of the
2,688 employees who reported headache, 344 (12.8 %)
requested and were given appointments. Of these, 211
(7.8 %) consulted and 133 (4.9 %) failed to attend
(Table 3). Attendance was related to headache frequency,
increasing from 2.9 % of those with one headache in the
preceding month to 25.7 % of those with headache on
10–14 days/month (Table 3) (Pearson correlation: 0.200
[P <0.0005]).
Of the 211 employees who came to the headache
clinic, 171 were blue-collar (3.5 % of the participating
blue-collar workforce) and 40 were white-collar (3.9 %
of the participating white-collar workforce). Of the 133
employees who failed to attend, 111 were blue-collar
(2.3 %) and 22 were white-collar (2.2 %). These differ-
ences were not significant.
Outcomes
Of the 211 who consulted for first appointments, only
73 (34.6 %) returned for follow-up appointments, and
few of these did so at the times prescribed, which were
appropriate for their optimum management. This greatly
hindered their management. It also meant that outcome
measurements were insufficient for useful analysis of
outcomes. Therefore we have not reported them.
Discussion
This year-long observational study confirmed, in a young
mostly male workforce, the high productivity losses at-
tributable to headache—by far the greater part being due
to presenteeism rather than absenteeism. Also, a dispro-
portionately large part was due to a small minority of
employees with high-frequency headache. The findings
are very much in agreement with those of our earlier
study, which employed two different survey methods [9],
but are preferable because they eliminate any seasonal
effect. Employees were offered free health care on site in
an attempt to show that productivity losses were at least
in part recoverable. The attempt failed, because this ap-
parently highly disabled workforce took little advantage
of the offer.
In our methods, we diverged from our earlier study [9]
by using HALT-30 rather than the standard HALT-90
Index. The latter counts days affected by headache during
the preceding 3 months [13]. This balances the need in a
therapeutic encounter with an individual patient to reflect
his or her illness over a period of time against the prob-
lems of recall error when that period is prolonged. In a
population measure, with a large sample, there was no
need to reflect the states of individuals, whereas a measure
over a shorter period of 1 month was likely to be more re-
liable through better recall. We assumed, in the total
population, that annual lost time was correctly estimated
from the sum of individual HALT-30 scores x 12.
In a workforce with a mean age of 32.5 years and
92.7 % male, we evaluated the effect of headache on
productivity without classifying headache type. One-
month prevalence of any headache was 45.4 %, very
close to the 43.2 % we found previously [9]. While this
estimate included migraine, TTH and all causes of head-
ache occurring on ≥15 days/month, it cannot easily be
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Table 1 Absenteeism, presenteeism, total productivity losses and average productivity losses per employee with headache according to headache frequency
Headache frequency
(days/month)
N (% of
sample)
n (% of sample) [% of
N] with productivity loss
Absenteeism (total days
in preceding 30 days)
Presenteeism (total days
in preceding 30 days)
Ratio absenteeism
to presenteeism
Total productivity loss (total
[%] days in preceding 30 days)
Average productivity loss
per employee (days/month)
≤1 627 (10.6) 120 (2.0) [19.1] 30 112 0.27 142 [14.7] 0.23
2–4 1,385 (23.4) 442 (7.4) [31.9] 66 857 0.08 923 [28.6] 0.67
5–9 438 (7.4) 238 (4.0) [54.3] 47 806 0.06 853 [26.4] 1.95
10–14 148 (2.5) 104 (1.8) [70.3] 21 577 0.04 598 [18.5] 4.04
≥15 90 (1.5) 64 (1.1) [71.1] 26 654 0.04 680 [21.1] 7.56
Totals 2,688 (45.4) 968 (16.3) [36.0] 190 3,036 0.06 3,226 [100] 1.20
Selekler
et
al.The
Journalof
H
eadache
and
Pain
 (2015) 16:96 
Page
5
of
8
related to estimates of 1-year prevalence [9] since a pro-
portion of those with headache occurring less than once
a month would have been excluded. Because of aver-
aging, this did not impair the estimate of population
burden, which we found in this young and mostly male
workforce to be high, as we did previously [9]. Import-
antly, by carrying out a new year-long evaluation, we
eliminated any influence of seasonal effect.
Lost productivity in the whole workforce was esti-
mated at 6,452 hours/week, with a mean lost productive
time per employee reporting any productivity loss (ab-
senteeism and/or presenteeism) (n = 968) of 6.7 hours/
week. There are few studies offering comparison [17–23]
but, in one in the United States, Stewart et al. [17]
reported mean productivity losses of 4.7 hours/week for
migraine. In another [18], they investigated lost product-
ive times due to each of a range of common pain condi-
tions in the US workforce. The mean lost productive
time for all headache types was 3.5 hours/week. These
losses were lower than ours, which might be surprising
since the US studies were population-based volunteer
cohort studies selected to be representative of mixed
workforces of the US population, while ours specifically
targeted a rather homogenous group of young and mostly
male employees working in a heavy-manufacturing indus-
try in Turkey.
We do not wish to make too much of this. Compari-
sons with other countries with different cultures,
dependent on studies using different methodologies
and sampling methods and achieving lower participa-
tion rates, may not be of primary interest here. Fur-
thermore, the possible reasons for high productivity
losses in our particular workforce have been discussed
before [9].
A consideration of more immediate relevance is the
very high dependence of lost productivity on head-
ache frequency (Table 1): while the group with head-
ache on ≥15 days/month were 6.6 % (64/968) of the
disabled group, they were responsible for a dispropor-
tionate 21.1 % of the productivity losses. The respect-
ive proportions for those with 5–14 headache days/
month were 35.3 % (n = 342) and 45.9 %, while those
with <5 headache days/month were 58.1 % (n = 562)
of the disabled group and caused 58.1 % of the prod-
uctivity losses. In other words, disproportionate prod-
uctivity loss is seen with headache frequencies above
once a week.
Yet the proportion of employees in our workforce with
headache on ≥15 days/month (1.5 %) was low in com-
parison with findings of epidemiological studies [24, 25].
High-frequency headache does not sufficiently explain
the high productivity losses in our workforce. Productiv-
ity losses were higher among female employees than
males, as found elsewhere [2–6, 26], but, since our work-
force was mostly male, this offers no explanation. As for
the nature of the work (physically demanding for the ma-
jority of employees), although there was no difference in
mean headache frequency between white- and blue-collar
employees, headache on ≥15 days/month was more than
twice as prevalent among the latter. Rate of absenteeism
was two-fold higher in blue-collar employees while there
was no difference in respect of presenteeism or overall lost
productivity.
In summary, while productivity loss is clearly related
to headache frequency, other not yet apparent explana-
tions must be invoked for the high productivity losses in
this workforce. It is worth noting that the absenteeism/
presenteeism ratio was 1/16. Although again this was in
Table 3 Employees requesting and attending appointments with the headache clinic according to headache frequency
Headache frequency
(days/month)
Employees with
headache (N = 2,688)
Employees requesting and receiving appointments (n = 344)
Employees consulting (n = 211) Employees failing to
attend (n = 133)
0–1 627 18 (2.9 %) 4 (0.6 %)
2–4 1,385 76 (5.5 %) 52 (3.8 %)
5–9 438 59 (13.5 %) 48 (11.0 %)
10–14 148 38 (25.7 %) 13 (8.8 %)
≥15 90 20 (22.2 %) 16 (17.8 %)
Table 2 Absenteeism, presenteeism and total productivity loss (mean days/month) per employee according to age
Age range (years) 20–24 25–29 30–34 35–39 ≥40
(n = 415) (n = 1,454) (n = 2,161) (n = 1,331) (n = 555)
Absenteeism 0.05 0.05 0.04 0.01 0.01
Presenteeism 0.59 0.61 0.57 0.44 0.17
Total productivity loss 0.64 0.66 0.61 0.45 0.18
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complete concordance with our previous study [9], it is
much exaggerated compared with the findings of other
studies. We argued previously that this might be related
to social and economic issues peculiar to the country.
Incidentally, the ratio fell sharply as headache frequency
increased above once a month, which may support this
argument: absenteeism, being much more visible than
presenteeism, is far less tolerated by employers. An en-
tirely different explanation is also possible: as headache
frequency increases, a coping mechanism is deployed.
Perhaps the more interesting points for discussion, in
terms of their implications, arise from what we must re-
gard as the failure of the interventional study. This ap-
parently highly disabled workforce, suffering substantial
productivity losses, were offered free health care on site
and showed limited inclination to take advantage of it.
Explanations are speculative, and will need testing. The
first lies entirely with the employees: they had learnt to
live with their headaches, they had developed coping
mechanisms and they had low expectations for benefit
from health care. Such attitudes, which erect a signifi-
cant social barrier to health care, have been remarked
upon before [27]. With this explanation, those using the
service would have tended to be those worst affected, as
happened (Table 3). The second is that, although the
study was supported by senior management, employees
were prevented (or at least discouraged) from taking
time to attend by line-managers, to avoid local work dis-
ruptions. This would have appeared as a more random
factor, affecting all severities equally, and this might be
the case among those who made appointments but failed
to attend (Table 3).
The implications for employers, who should have an
interest in recovering lost productivity, are twofold. First,
the focus of any intervention should be on those with
frequent headache. Their numbers are relatively low but
the impact of their headaches is very high. Second, it is
not a sufficient intervention merely to make headache
care available, although it is by no means clear what
more needs to be done, or how to do it. The much wider
implications are that these truisms can be extrapolated
to the employed general public.
Conclusions
We confirmed in the year-long observational study the
high productivity losses in this young mostly male work-
force, which correlated with but were not wholly ex-
plained by headache frequency. In a socioeconomic
climate likely to discourage absenteeism, the absentee-
ism/presenteeism ratio was 1:16. As we found before, a
small minority of employees with high-frequency head-
ache contributed highly disproportionately to the product-
ivity losses, and these should be the target of interventions
aimed at productivity recovery. It is not clear what form
such interventions should take. Our finding was that mak-
ing headache care optimally available is, of itself, far short
of a solution.
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